Some are small; others, biological, and there are also medications already approved for another purpose that seek to help in ...

Science also found that a planned clinical trial for a stroke drug candidate that Zlokovic helped develop ... and as ...

Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...

While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...

Officials said over 71,000 Oklahomans are currently living with Alzheimer's disease. Nationally, that number is approaching 7 ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

The drug works by essentially forcing our cells to "spit out" dangerous protein clumps involved in Alzheimer's.

Can large national health plans make an impact in reducing prescribing of high-risk medications to people with Alzheimer's ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

After dosing with Cognition’s CT1812, study reports declines of 95% and higher in subgroup with below-median p-tau217.

Arizona is home to more than 150,000 people aged 65 and older who live with Alzheimer’s, or 11% of older residents.